Plain-English translation of NCT06841796 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a continuous glucose monitor called Stelo can help people with prediabetes prevent or delay the onset of type 2 diabetes. The monitor tracks your blood sugar in real time, giving you instant feedback about how your food and activity choices affect your glucose levels. The hope is that seeing this real-time information will motivate you to make healthier decisions and avoid developing diabetes.
Most people who need to prevent diabetes struggle to stick with lifestyle programs over time. Research shows that when people can see how their daily choices immediately affect their blood sugar, they're more likely to stay motivated and make lasting changes. This trial is testing whether this new treatment approach works better than traditional diabetes prevention programs.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you're chosen for the study, you'll be randomly assigned to one of two groups. One group will wear the Stelo glucose monitor for the full 24 weeks and use the real-time glucose feedback to guide lifestyle changes with the help of a health coach at your local YMCA. The other group will wear a hidden glucose monitor for brief periods (10 days at weeks 6, 12, and 24) but won't see the data. All participants will have check-ins at multiple timepoints over the 6-month study period to track progress.
AI-generated summary from trial data ยท Jun 16, 2026 ยท Not medical advice
United States